Developing tests to measure biological activity for pain management
BIOACTIVITY ASSAY DEVELOPMENT CONSULTING SERVICES
This study is working on new tests to see how well pain medications work and are safe, helping both doctors and researchers find better ways to manage pain for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Project ID | NIH-11211268 on NIH RePORTER |
What this research studies
This research focuses on creating and validating bioassays that can measure the effectiveness of drugs in managing pain. By employing expert consultants, the project aims to optimize these tests for both clinical and nonclinical studies. The bioassays will analyze biological samples, such as blood serum, to ensure that the drugs are safe and effective. This initiative is part of the NIH's HEAL initiative, which seeks to improve pain management strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing chronic pain who may benefit from improved pain management therapies.
Not a fit: Patients who do not suffer from chronic pain or related conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management solutions for patients suffering from chronic pain.
How similar studies have performed: Previous research has shown success in developing bioassays for drug testing, indicating that this approach has potential for meaningful advancements.
Where this research is happening
Lyme, United States
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.